Skandinaviska Enskilda Banken (SEB)’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-25,581
| Closed | -$737K | – | 841 |
|
|
2024
Q3 | $737K | Hold |
25,581
| – | – | ﹤0.01% | 695 |
|
|
2024
Q2 | $982K | Hold |
25,581
| – | – | ﹤0.01% | 645 |
|
|
2024
Q1 | $1.5M | Sell |
25,581
-4,900
| -16% | -$288K | 0.01% | 619 |
|
|
2023
Q4 | $1.82M | Buy |
30,481
+4,900
| +19% | +$293K | 0.01% | 602 |
|
|
2023
Q3 | $972K | Sell |
25,581
-3,860
| -13% | -$147K | 0.01% | 680 |
|
|
2023
Q2 | $2.68M | Hold |
29,441
| – | – | 0.02% | 492 |
|
|
2023
Q1 | $1.94M | Sell |
29,441
-1,405
| -5% | -$92.7K | 0.01% | 558 |
|
|
2022
Q4 | $1.6M | Sell |
30,846
-6,208
| -17% | -$321K | 0.01% | 591 |
|
|
2022
Q3 | $2.53M | Hold |
37,054
| – | – | 0.02% | 482 |
|
|
2022
Q2 | $1.68M | Hold |
37,054
| – | – | 0.01% | 616 |
|
|
2022
Q1 | $1.88M | Buy |
+37,054
| New | +$1.88M | 0.01% | 639 |
|